Conrad Wang, M.D., has joined HealthCare Royalty Partners as a Principal on the investment team. Wang most recently served as Senior Director, Corporate Development at Medtronic plc.
STAMFORD, Conn.–(BUSINESS WIRE)–HealthCare Royalty Partners (“HCRP”) today announced that it has expanded its team of investment professionals with the appointment of Conrad Wang, M.D.
Dr. Wang joins HCRP as a Principal on the investment team. He most recently served as Senior Director, Corporate Development at Medtronic plc, a medical device company, where he led cross-functional deal teams in evaluating and executing acquisitions, strategic alliances, joint ventures and minority investments. Prior to Medtronic, Dr. Wang was a principal investor at Three Arch Partners, a healthcare venture capital firm, where he sourced, invested in and was a board member for medical device, healthcare services and therapeutics companies. Dr. Wang received an M.B.A. from Harvard Business School, an M.D. from the Harvard-MIT Division of Health Sciences and Technology at Harvard Medical School, and a B.S. from Massachusetts Institute of Technology.
“We are very pleased to welcome Dr. Wang to the HCRP team, as he will be a powerful addition to the existing depth and expertise of our investment team,” said Dr. Gregory Brown, Founding Managing Director of HCRP. “Dr. Wang’s impressive background as an orthopedic surgeon; his operating and business development experience at Medtronic; and his principal investment experience in healthcare venture capital will add a valuable perspective on the financial needs and challenges facing our potential partners. We look forward to leveraging his talents and insights as we continue to grow our investment platform.”
The addition of Dr. Wang increases HCRP’s headcount to 24 professionals, including 3 M.D.’s or Ph.D.’s, as well as three professionals holding Masters degrees in scientific fields. HCRP’s in-house team is supplemented with the firm’s Strategic Advisory Board, which is comprised of seven prominent healthcare senior professionals. The firm is actively deploying capital from its most recent fund, HealthCare Royalty Partners III, L.P. and affiliated entities, which held a successful final closing on cumulative capital of $1.5 billion in November 2014.
About HealthCare Royalty Partners
HealthCare Royalty Partners (HCRP) is a global healthcare investment firm focused on investing primarily in commercial stage healthcare product assets. HCRP manages over $3 billion and is headquartered in Stamford, CT. Over the past decade, HCRP’s co-founders have completed more than 60 healthcare investments totaling more than $2.6 billion of capital. For more information, visit www.healthcareroyalty.com.